- Home
- Publications
- Publication Search
- Publication Details
Title
Soluble Amyloid-β Consumption in Alzheimer’s Disease
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 82, Issue 4, Pages 1403-1415
Publisher
IOS Press
Online
2021-06-16
DOI
10.3233/jad-210415
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease
- (2021) Reisa Sperling et al. JAMA Neurology
- Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
- (2021) Günter U Höglinger et al. LANCET NEUROLOGY
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis
- (2021) Sarah F Ackley et al. BMJ-British Medical Journal
- The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up
- (2020) Gøril Rolfseng Grøntvedt et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid β-protein and beyond: the path forward in Alzheimer’s disease
- (2020) Dominic M Walsh et al. CURRENT OPINION IN NEUROBIOLOGY
- Kinetic diversity of amyloid oligomers
- (2020) Alexander J. Dear et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disentangling the Amyloid Pathways: A Mechanistic Approach to Etiology
- (2020) Maja Malmberg et al. Frontiers in Neuroscience
- A 3D human brain–like tissue model of herpes-induced Alzheimer’s disease
- (2020) Dana M. Cairns et al. Science Advances
- The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
- (2020) Sarah A. Kent et al. ACTA NEUROPATHOLOGICA
- Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
- (2020) Kevin Mullane et al. BIOCHEMICAL PHARMACOLOGY
- Shifts and drifts in prion science
- (2020) Adriano Aguzzi et al. SCIENCE
- Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating
- (2020) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases
- (2019) Alberto J. Espay et al. NEUROLOGY
- The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies
- (2019) Eider M Arenaza-Urquijo et al. BRAIN
- The viral protein corona directs viral pathogenesis and amyloid aggregation
- (2019) Kariem Ezzat et al. Nature Communications
- Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework
- (2019) Clifford R. Jack et al. JAMA Neurology
- Questions EMERGE as Biogen claims aducanumab turnaround
- (2019) Robert Howard et al. Nature Reviews Neurology
- A resurrection of aducanumab for Alzheimer's disease
- (2019) Lon Schneider LANCET NEUROLOGY
- Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes
- (2018) Johnny Habchi et al. Nature Chemistry
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- Memory decline accompanies subthreshold amyloid accumulation
- (2018) Susan M. Landau et al. NEUROLOGY
- Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in Taiwan
- (2018) Nian-Sheng Tzeng et al. Neurotherapeutics
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Load of Amyloid-β Oligomers is Decreased in the Cerebrospinal Fluid of Alzheimer's Disease Patients
- (2018) Giulia M. Sancesario et al. JOURNAL OF ALZHEIMERS DISEASE
- Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
- (2018) Eric McDade et al. NEUROLOGY
- The antimicrobial protection hypothesis of Alzheimer's disease
- (2018) Robert D. Moir et al. Alzheimers & Dementia
- Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults
- (2018) Michelle E. Farrell et al. NEUROLOGY
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
- (2017) Michael C. Donohue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα
- (2017) Bruce G. Mockett et al. Frontiers in Molecular Neuroscience
- Alzheimer disease: modeling an Aβ-centered biological network
- (2016) D Campion et al. MOLECULAR PSYCHIATRY
- The activities of amyloids from a structural perspective
- (2016) Roland Riek et al. NATURE
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- In vivo aspects of protein folding and quality control
- (2016) D. Balchin et al. SCIENCE
- Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease
- (2016) Deepak Kumar Vijaya Kumar et al. Science Translational Medicine
- Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer’s disease mouse model
- (2015) Romain Fol et al. ACTA NEUROPATHOLOGICA
- Immunotherapies in Alzheimer’s disease: Too much, too little, too late or off-target?
- (2015) Isabelle St-Amour et al. ACTA NEUROPATHOLOGICA
- The Neuropathology of Chronic Traumatic Encephalopathy
- (2015) Ann C. McKee et al. BRAIN PATHOLOGY
- Role of Amylin in Type 1 and Type 2 Diabetes
- (2015) Laura Hieronymus et al. DIABETES EDUCATOR
- The association between infectious burden and Parkinson's disease: A case-control study
- (2015) Xian-Le Bu et al. PARKINSONISM & RELATED DISORDERS
- Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons
- (2015) Maria L. Giuffrida et al. Frontiers in Cellular Neuroscience
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- Altered Cerebrospinal Fluid Levels of Amyloid β and Amyloid Precursor-Like Protein 1 Peptides in Down’s Syndrome
- (2014) Erik Portelius et al. NEUROMOLECULAR MEDICINE
- Effect of Proline Mutations on the Monomer Conformations of Amylin
- (2013) Chi-cheng Chiu et al. BIOPHYSICAL JOURNAL
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints
- (2012) Argonde C. van Harten et al. Alzheimers & Dementia
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia
- (2012) A. B. Balasubramanian et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amyloid-β associated volume loss occurs only in the presence of phospho-tau
- (2011) Rahul S. Desikan et al. ANNALS OF NEUROLOGY
- Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
- (2011) Prashanthi Vemuri et al. BRAIN
- Neuronal activity regulates the regional vulnerability to amyloid-β deposition
- (2011) Adam W Bero et al. NATURE NEUROSCIENCE
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- -Amyloid Monomers Are Neuroprotective
- (2009) M. L. Giuffrida et al. JOURNAL OF NEUROSCIENCE
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- APOE 2 is associated with intact cognition but increased Alzheimer pathology in the oldest old
- (2009) D. J. Berlau et al. NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started